Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;21(2):157-166.
doi: 10.1007/s10689-021-00261-1. Epub 2021 May 10.

Pilot study of an online training program to increase genetic literacy and communication skills in oncology healthcare professionals discussing BRCA1/2 genetic testing with breast and ovarian cancer patients

Affiliations

Pilot study of an online training program to increase genetic literacy and communication skills in oncology healthcare professionals discussing BRCA1/2 genetic testing with breast and ovarian cancer patients

Bettina Meiser et al. Fam Cancer. 2022 Apr.

Abstract

The increasing use of genetic testing for BRCA1/2 and other pathogenic variants in the management of women with breast and ovarian cancer necessitates increased genetic literacy in oncology healthcare professionals. This pilot study aimed to evaluate an online training program to increase genetic literacy and communication skills in Australian oncology healthcare professionals tasked with discussing and coordinating mainstream genetic testing with breast and ovarian cancer patients. A training website with embedded videos was developed. This study assesses the website's acceptability and user-friendliness; suggestions for improvement were also elicited. Oncology healthcare professionals were recruited through relevant professional organisations, invited to the study by email, asked to work through the website and then complete an online questionnaire. Thirty-two oncology healthcare professionals completed the questionnaire after viewing the website. Nearly all participants were satisfied with the information contained in the program (very satisfied: n = 14/32, 44%, satisfied: n = 17/32, 53%, neither satisfied nor dissatisfied: n = 1/32, 3%) and reported that they had gained new skills (n = 29/32, 91%) and had increased confidence (n = 29/31, 94%) in communicating with breast and ovarian cancer patients about genetic testing. More than 93% (28/30) of participants endorsed the online program as clearly presented, informative, relevant and useful. This pilot study demonstrated high feasibility and acceptability of the training program to increase genetic literacy and communication skills in oncology healthcare professionals discussing genetic testing with breast and ovarian cancer patients. Further evidence from a randomised trial is needed to evaluate effects on changing clinical practice, improving patient outcomes, and cost-effectiveness.

Keywords: BRCA1; BRCA2; Breast cancer; Communication training; Genetic testing; Oncology healthcare professionals; Online training; Ovarian cancer.

PubMed Disclaimer

Conflict of interest statement

Margaret Gleeson and Maira Kentwell declare remunerated consultant roles with the company AstraZeneca with respect to activities unrelated to this article. Paula Woodward had a remunerated consultant role with respect to the current study. The other authors declare that they have no conflicts of interest.

Figures

Fig. 1
Fig. 1
Examples of reinforcing activities
Fig. 2
Fig. 2
Percentage of participants endorsing modules of training program as “very…

References

    1. Moore K, Colombo N, Scambia G, et al. Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer. N Engl J Med. 2018;379:2495–2505. doi: 10.1056/NEJMoa1810858. - DOI - PubMed
    1. Puiade-Lauraine E, Ledermann J, Selle F, et al. Olaparib tablets as maintenance therapy in patients with platinum- sensitive, relapsed ovarian cancer and A BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet. 2017;8(9):1274–1284. doi: 10.1016/S1470-2045(17)30469-2. - DOI - PubMed
    1. Mirza M, Monk B, Herrstedt J, et al. Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer. N Engl J Med. 2016;375:2154–2164. doi: 10.1056/NEJMoa1611310. - DOI - PubMed
    1. Hartmann LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med. 1999;340(2):77–84. doi: 10.1056/NEJM199901143400201. - DOI - PubMed
    1. Evans D, Ingham S, Baildam A, et al. Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer. Breast Cancer Res Treat. 2013;140(1):135–142. doi: 10.1007/s10549-013-2583-1. - DOI - PubMed